NCT02572362View on ClinicalTrials.gov

Secondary Cancer Risk After Radiation Therapy for Rectal Cancer

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Neoplasms, Second Primary
Interventions
OTHER

No intervention in this retrospective study

No Intervention in this retrospective Analysis. All patients included did receive Radiation therapy Independent of this study

Trial Locations (1)

CH-8032

Klinik Hirslanden, Institute for Radiotherapy, Zurich

All Listed Sponsors
collaborator

Klinik Hirslanden, Zurich

OTHER

lead

Kantonsspital Graubuenden

OTHER

NCT02572362 - Secondary Cancer Risk After Radiation Therapy for Rectal Cancer | Biotech Hunter | Biotech Hunter